Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : NIFTY NINE IN NINETY NINE PLUS ONE -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (381)	2/6/1999 9:39:00 AM
From: Arthur Radley	Read Replies (1) \| Respond to of 613

Mike, With our interest in gene technology, and with the Russians having more problems with the MIR this week, I thought I would suggest a book for you to read. If you would indulge me by allowing me to bring family into our discussion I would suggest you read..."Dragonfly" by Bryan Burrough, who also co-wrote "Barbarians at the Gate". "Dragonfly" is about NASA and the crisis aboard MIR. The connection to the issue of genes is the fact that my first cousin, Dr. Norm Thagard was the first American to go up and stay on MIR and after reading this book and looking at my profile you will note the gene pool in my family wasn't evenly distributed. However, after seeing a picture of Norm in the book and maybe remembering him from national TV, you must know that I'm better looking than he and I have a full head of hair.(:>)

To: Mike McFarland who wrote (381)	2/6/1999 3:02:00 PM
From: Steve Lokness	Read Replies (1) \| Respond to of 613

Mike; Terrific link with incredible news on Beplers work. Thank you very much for posting it. While you are sure correct that these biotechs have not behaved like internet stocks, someday I believe they will and those who have done their homework could be real winners. You would expect that Bepler would patent this finding, but I see no mention of it. What he has done is put the information into the public domain. Isn't this just the type of information that companies such as GLGC try to make available to their customers? Mike, I think it was you who got me thinking about CTII. I talked some with Elizabeth yesterday, but am worried some by their cash available. Do you think they will be able to keep up current work without such dilution as is often seen with these biotechs? Thanks; Steve